GIORGETTI, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 365
AS - Asia 162
NA - Nord America 92
SA - Sud America 10
AF - Africa 3
Totale 632
Nazione #
IT - Italia 347
US - Stati Uniti d'America 84
SG - Singapore 53
BD - Bangladesh 41
CN - Cina 28
VN - Vietnam 27
BR - Brasile 6
HK - Hong Kong 6
CA - Canada 5
DE - Germania 5
FR - Francia 4
AR - Argentina 2
FI - Finlandia 2
GB - Regno Unito 2
ID - Indonesia 2
AT - Austria 1
BO - Bolivia 1
EC - Ecuador 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
LB - Libano 1
LT - Lituania 1
MG - Madagascar 1
MX - Messico 1
NL - Olanda 1
RO - Romania 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 632
Città #
Genoa 301
Singapore 30
San Jose 16
Ho Chi Minh City 14
Vado Ligure 14
Council Bluffs 8
Beijing 6
Hong Kong 6
Rapallo 6
Ashburn 5
Los Angeles 5
Buffalo 4
Frankfurt am Main 4
New York 4
Hanoi 3
Lauterbourg 3
Milan 3
Santa Clara 3
Shenzhen 3
Boardman 2
Haiphong 2
Helsinki 2
Palermo 2
Phoenix 2
Amsterdam 1
Antakya 1
Antananarivo 1
Bergenfield 1
Biên Hòa 1
Brantford 1
Buenos Aires 1
Cairo 1
Chicago 1
Cuenca 1
Dallas 1
Depok 1
Des Moines 1
Durban 1
Florence 1
Formosa 1
Glace Bay 1
Grand Prairie 1
Guatemala City 1
Houston 1
Hải Dương 1
Indianapolis 1
Karbala 1
Kyiv 1
La Paz 1
London 1
Massarosa 1
Miami 1
Mumbai 1
Nuremberg 1
Ontario 1
Orem 1
Osasco 1
Paulista 1
Pimenta Bueno 1
Ploieşti 1
Ponte dell'Olio 1
Poplar 1
Prato 1
Pulversheim 1
Quảng Nam Province 1
Rome 1
Salt Lake City 1
Saquarema 1
Sassuolo 1
Schenectady 1
Schiavon 1
Sidon 1
São Paulo 1
Thái Nguyên 1
Tokyo 1
Turin 1
Ubá 1
Vancouver 1
Venice 1
Whitby 1
Yoakum 1
Ân Thi 1
Totale 506
Nome #
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 172
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 168
CD56-OVEREXPRESSING MYELOMA CELLS ARE MORE VULNERABLE TO NAD+ EXHAUSTING STRATEGIES DUE TO DEPENDENCY ON CD38 ENZYMATIC ACTIVITY 102
Higher CD56 Expression on Multiple Myeloma Cells Increases CD38 Expression, Reduces Intracellular NAD+ Levels, and Enhances the Efficacy of Daratumumab-Based Treatment Strategies 62
The NAD + Metabolic Dependency Restriction Overcomes Drug-Resistance Phenotype of Multiple Myeloma CELLS 48
A Novel Ribonuclease Targeting Small Molecule RNA-Degrader (MYC-RiboTAC) Overcomes MYC Dependency in Multiple Myeloma 34
Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies 31
PKMYT1 Kinase Is an Actionable Synthetically Lethal Target for Del17p Myeloma 21
Partial Inhibition Of Nampt Restores Metabolic Vulnerability And Synergizes With Anti-Myeloma Agents In Multiple Myeloma 10
Totale 648
Categoria #
all - tutte 1.661
article - articoli 1.019
book - libri 0
conference - conferenze 473
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 0 0 0 2 0 3 3 2
2023/202432 1 3 7 7 4 2 1 4 1 0 0 2
2024/2025139 3 3 3 3 3 12 6 16 6 22 25 37
2025/2026467 45 18 48 54 47 22 33 27 33 33 74 33
Totale 648